Universe · entity
Cormorant Asset Management, LP
Institutional manager (13F) · CIK 1583977
13F holdings · as of 2026-03-31 · top 46 · reported portfolio $2.0B
| # | Issuer | Value | Shares |
|---|---|---|---|
| 1 | PRAXIS PRECISION MEDICINES I | $285M | 885,500 |
| 2 | BRIDGEBIO ONCOLOGY THERAPEUT | $160M | 17,878,594 |
| 3 | EYEPOINT INC | $107M | 8,265,000 |
| 4 | EDGEWISE THERAPEUTICS INC | $103M | 3,260,000 |
| 5 | ERASCA INC | $94M | 5,800,000 |
| 6 | RAPPORT THERAPEUTICS INC | $93M | 2,957,521 |
| 7 | ALUMIS INC | $87M | 3,949,241 |
| 8 | ABIVAX SA | $85M | 760,000 |
| 9 | MOONLAKE IMMUNOTHERAPEUTICS | $84M | 4,480,433 |
| 10 | DIANTHUS THERAPEUTICS INC | $80M | 950,000 |
| 11 | BRIGHT MINDS BIOSCIENCES INC | $77M | 1,059,331 |
| 12 | BRIDGEBIO PHARMA INC | $63M | 850,000 |
| 13 | OLEMA PHARMACEUTICALS INC | $58M | 3,900,000 |
| 14 | BIOAGE LABS INC | $51M | 2,890,605 |
| 15 | CENTESSA PHARMACEUTICALS PLC | $42M | 1,050,000 |
| 16 | DAMORA THERAPEUTICS INC | $39M | 1,525,000 |
| 17 | MBX BIOSCIENCES INC | $33M | 1,120,000 |
| 18 | INSMED INC | $31M | 190,000 |
| 19 | NEWAMSTERDAM PHARMA COMPANY | $30M | 950,000 |
| 20 | TANGO THERAPEUTICS INC | $30M | 1,425,000 |
| 21 | PHARVARIS N V | $28M | 1,000,000 |
| 22 | ORUKA THERAPEUTICS INC | $26M | 533,340 |
| 23 | AGOMAB THERAPEUTICS NV | $26M | 2,465,348 |
| 24 | MAZE THERAPEUTICS INC | $22M | 750,000 |
| 25 | CORBUS PHARMACEUTICALS HLDGS | $22M | 2,344,971 |
| 26 | ASCENDIS PHARMA A/S | $22M | 95,000 |
| 27 | ROIVANT SCIENCES LTD | $21M | 750,000 |
| 28 | ADLAI NORTYE LTD | $20M | 2,897,857 |
| 29 | TERNS PHARMACEUTICALS INC | $16M | 300,000 |
| 30 | TARSUS PHARMACEUTICALS INC | $16M | 225,000 |
| 31 | BIOHAVEN LTD | $15M | 1,760,000 |
| 32 | CABALETTA BIO INC | $15M | 5,500,000 |
| 33 | HELIX ACQUISITION CORP III | $13M | 1,297,500 |
| 34 | ARCUTIS BIOTHERAPEUTICS INC | $11M | 450,000 |
| 35 | SENSEI BIOTHERAPEUTICS INC | $10M | 306,222 |
| 36 | CRINETICS PHARMACEUTICALS IN | $9M | 250,000 |
| 37 | ZURA BIO LTD | $9M | 1,450,000 |
| 38 | AXSOME THERAPEUTICS INC. | $8M | 50,000 |
| 39 | STRUCTURE THERAPEUTICS INC | $8M | 175,000 |
| 40 | COGENT BIOSCIENCES INC | $8M | 200,000 |
| 41 | MONTE ROSA THERAPEUTICS INC | $7M | 400,000 |
| 42 | ARROWHEAD PHARMACEUTICALS IN | $6M | 100,000 |
| 43 | VAXCYTE INC | $6M | 100,000 |
| 44 | AMYLYX PHARMACEUTICALS INC | $5M | 350,000 |
| 45 | RALLYBIO CORP | $4M | 400,000 |
| 46 | CONTEXT THERAPEUTICS INC | $1M | 529,550 |
Source: sec_edgar_13f · public regulatory · retrieved 2026-06-29. Public SEC data; no contact information.